معرفی
Hani Alsafadi is a Postdoc and Researcher at Lund University's Faculty of Medicine, specializing in lung biology and regeneration research. They are affiliated with multiple research initiatives including Lung Bioengineering and Regeneration, StemTherapy (National Initiative on Stem Cells for Regenerative Therapy), and NanoLund (Centre for Nanoscience), and serve as a profile area member for Nanoscience and Semiconductor Technology as well as Light and Materials at Lund University.
Their research focuses on critical areas of pulmonary medicine:
- Hippo Signaling pathways in lung tissue
- Idiopathic Pulmonary Fibrosis mechanisms and treatments
- Ex vivo models and precision-cut tissue slices
- Lung epithelial cell biology
- Extracellular matrix in pulmonary diseases
Alsafadi completed their doctoral thesis in 2023 titled 'Role of the co-transcriptional regulators Yap/Taz in the normal and fibrotic lung epithelia' under Lund University's Faculty of Medicine. Their work contributes to UN Sustainable Development Goals related to health and well-being, particularly in advancing treatments for respiratory diseases.
Analysis of their recent publications reveals a strong focus on developing innovative models for studying pulmonary fibrosis, with particular emphasis on YAP/TAZ signaling pathways, stem cell-derived organoids, and ex vivo tissue engineering approaches. Their research bridges basic science with potential clinical applications, especially in identifying novel antifibrotic therapeutics.
Alsafadi is actively involved in two major research projects:
- Biomaterials@LU (ongoing since September 2023) as a Researcher
- Context dependence of the hippo signaling pathway in pulmonary fibrosis (2018-2022) as a Researcher under David Wagner's supervision
Their scholarly work demonstrates significant impact, with multiple publications receiving citations, media mentions, and substantial engagement on academic platforms like Mendeley.
